{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T22:33:30Z","timestamp":1792967610180,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00787-026-03097-1","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:24:02Z","timestamp":1781857442000},"page":"3293-3301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disruptive mood dysregulation disorder and pediatric bipolar disorder: diagnostic and prescribing trends following DSM-5"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5146-4575","authenticated-orcid":false,"given":"Ching-Fang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7254-5646","authenticated-orcid":false,"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-291X","authenticated-orcid":false,"given":"Chen-Yu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8860-5300","authenticated-orcid":false,"given":"Soo-Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"3097_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Washington DC","edition":"5th edn"},{"issue":"6","key":"3097_CR2","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1176\/appi.ajp.2012.12010132","volume":"171","author":"WE Copeland","year":"2014","unstructured":"Copeland WE, Angold A, Costello EJ, Egger H (2014) Prevalence, comorbidity, and correlates of DSM-5 disruptive mood dysregulation disorder. Am J Psychiatry 171(6):668\u2013674. https:\/\/doi.org\/10.1176\/appi.ajp.2012.12010132","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3097_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1176\/appi.ajp.2010.10050766","volume":"168","author":"E Leibenluft","year":"2011","unstructured":"Leibenluft E (2011) Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths. Am J Psychiatry 168(2):129\u2013142. https:\/\/doi.org\/10.1176\/appi.ajp.2010.10050766","journal-title":"Am J Psychiatry"},{"issue":"2","key":"3097_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/s0165-0327(98)00175-x","volume":"51","author":"B Geller","year":"1998","unstructured":"Geller B, Williams M, Zimerman B, Frazier J, Beringer L, Warner KL (1998) Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling. J Affect Disord 51(2):81\u201391. https:\/\/doi.org\/10.1016\/s0165-0327(98)00175-x","journal-title":"J Affect Disord"},{"issue":"3","key":"3097_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/104454603322572598","volume":"13","author":"R Tillman","year":"2003","unstructured":"Tillman R, Geller B (2003) Definitions of rapid, ultrarapid, and ultradian cycling and of episode duration in pediatric and adult bipolar disorders: a proposal to distinguish episodes from cycles. J Child Adolesc Psychopharmacol 13(3):267\u2013271. https:\/\/doi.org\/10.1089\/104454603322572598","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"3097_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1192\/bjpo.bp.115.001933","volume":"1","author":"J Clacey","year":"2015","unstructured":"Clacey J, Goldacre M, James A (2015) Paediatric bipolar disorder: international comparisons of hospital discharge rates 2000\u20132010. BJPsych Open 1(2):166\u2013171. https:\/\/doi.org\/10.1192\/bjpo.bp.115.001933","journal-title":"BJPsych Open"},{"issue":"9","key":"3097_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.biopsych.2006.08.042","volume":"60","author":"MA Brotman","year":"2006","unstructured":"Brotman MA, Schmajuk M, Rich BA, Dickstein DP, Guyer AE, Costello EJ, Egger HL, Angold A, Pine DS, Leibenluft E (2006) Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. Biol Psychiatry 60(9):991\u2013997. https:\/\/doi.org\/10.1016\/j.biopsych.2006.08.042","journal-title":"Biol Psychiatry"},{"issue":"8","key":"3097_CR8","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1176\/appi.ajp.2007.06101619","volume":"164","author":"MA Brotman","year":"2007","unstructured":"Brotman MA, Kassem L, Reising MM, Guyer AE, Dickstein DP, Rich BA, Towbin KE, Pine DS, McMahon FJ, Leibenluft E (2007) Parental diagnoses in youth with narrow phenotype bipolar disorder or severe mood dysregulation. Am J Psychiatry 164(8):1238\u20131241. https:\/\/doi.org\/10.1176\/appi.ajp.2007.06101619","journal-title":"Am J Psychiatry"},{"issue":"1\u20132","key":"3097_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jad.2009.05.022","volume":"121","author":"A Duffy","year":"2010","unstructured":"Duffy A, Alda M, Hajek T, Sherry SB, Grof P (2010) Early stages in the development of bipolar disorder. J Affect Disord 121(1\u20132):127\u2013135. https:\/\/doi.org\/10.1016\/j.jad.2009.05.022","journal-title":"J Affect Disord"},{"issue":"2","key":"3097_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1192\/bjp.bp.113.126706","volume":"204","author":"A Duffy","year":"2014","unstructured":"Duffy A, Horrocks J, Doucette S, Keown-Stoneman C, McCloskey S, Grof P (2014) The developmental trajectory of bipolar disorder. Br J Psychiatry 204(2):122\u2013128. https:\/\/doi.org\/10.1192\/bjp.bp.113.126706","journal-title":"Br J Psychiatry"},{"issue":"3","key":"3097_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4088\/jcp.15r10435","volume":"78","author":"C Cervesi","year":"2017","unstructured":"Cervesi C, Park SY, Galling B, Molteni S, Masi G, Gerhard T, Olfson M, Correll CU (2017) Extent, time course, and moderators of antipsychotic treatment in youth with mood disorders: results of a meta-analysis and meta-regression analyses. J Clin Psychiatry 78(3):347\u2013357. https:\/\/doi.org\/10.4088\/jcp.15r10435","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"3097_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaac.2024.07.920","volume":"64","author":"G Vita","year":"2025","unstructured":"Vita G, N\u00f6hles VB, Ostuzzi G, Barbui C, Tedeschi F, Heuer FH, Keller A, DelBello MP, Welge JA, Blom TJ, Kowatch RA (2025) Systematic review and network meta-analysis: efficacy and safety of antipsychotics vs antiepileptics or lithium for acute mania in children and adolescents. J Am Acad Child Adolesc Psychiatry 64(2):143\u2013157. https:\/\/doi.org\/10.1016\/j.jaac.2024.07.920","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"3097_CR13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/wps.20765","volume":"19","author":"M Solmi","year":"2020","unstructured":"Solmi M, Fornaro M, Ostinelli EG, Zangani C, Croatto G, Monaco F, Krinitski D, Fusar-Poli P, Correll CU (2020) Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry 19(2):214\u2013232. https:\/\/doi.org\/10.1002\/wps.20765","journal-title":"World Psychiatry"},{"issue":"1","key":"3097_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/wps.21279","volume":"24","author":"M H\u00f8jlund","year":"2025","unstructured":"H\u00f8jlund M, Wesselhoeft R, Heinrichsen M, Pagsberg AK, Correll CU, Steinhausen HC (2025) Excess cardiometabolic risk in children and adolescents initiating antipsychotic treatment compared to young adults: results from a nationwide cohort study. World Psychiatry 24(1):103\u2013112. https:\/\/doi.org\/10.1002\/wps.21279","journal-title":"World Psychiatry"},{"key":"3097_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jad.2019.12.018","volume":"264","author":"J Le","year":"2020","unstructured":"Le J, Feygin Y, Creel L, Lohr WD, Jones VF, Williams PG, Myers JA, Pasquenza N, Davis DW (2020) Trends in diagnosis of bipolar and disruptive mood dysregulation disorders in children and youth. J Affect Disord 264:242\u2013248. https:\/\/doi.org\/10.1016\/j.jad.2019.12.018","journal-title":"J Affect Disord"},{"issue":"3","key":"3097_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jaac.2021.05.016","volume":"61","author":"RL Findling","year":"2022","unstructured":"Findling RL, Zhou X, George P, Chappell PB (2022) Diagnostic trends and prescription patterns in disruptive mood dysregulation disorder and bipolar disorder. J Am Acad Child Adolesc Psychiatry 61(3):434\u2013445. https:\/\/doi.org\/10.1016\/j.jaac.2021.05.016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3097_CR17","unstructured":"TriNetX LLC (2026) TriNetX Research Network. https:\/\/trinetx.com"},{"issue":"2","key":"3097_CR18","doi-asserted-by":"publisher","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Mowll J, Wadhwa E, Blumenthal J, Deatrick K, Boivin G, Phan A (2023) A global federated real-world data and analytics platform for research. JAMIA Open 6(2):ooad035. https:\/\/doi.org\/10.1093\/jamiaopen\/ooad035","journal-title":"JAMIA Open"},{"issue":"1","key":"3097_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/ije\/dyw098","volume":"46","author":"JL Bernal","year":"2017","unstructured":"Bernal JL, Cummins S, Gasparrini A (2017) Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 46(1):348\u2013355. https:\/\/doi.org\/10.1093\/ije\/dyw098","journal-title":"Int J Epidemiol"},{"issue":"4","key":"3097_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27(4):299\u2013309. https:\/\/doi.org\/10.1046\/j.1365-2710.2002.00430.x","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"3097_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/s0006-3223(00)00911-2","volume":"48","author":"J Biederman","year":"2000","unstructured":"Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J (2000) Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry 48(6):458\u2013466. https:\/\/doi.org\/10.1016\/s0006-3223(00)00911-2","journal-title":"Biol Psychiatry"},{"issue":"4","key":"3097_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1034\/j.1399-5618.2001.30405.x","volume":"3","author":"RL Findling","year":"2001","unstructured":"Findling RL, Gracious BL, McNamara NK, Youngstrom EA, Demeter CA, Branicky LA, Calabrese JR (2001) Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disord 3(4):202\u2013210. https:\/\/doi.org\/10.1034\/j.1399-5618.2001.30405.x","journal-title":"Bipolar Disord"},{"issue":"1","key":"3097_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/01.chi.0000242240.69678.c4","volume":"46","author":"J McClellan","year":"2007","unstructured":"McClellan J, Kowatch R, Findling RL (2007) Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 46(1):107\u2013125. https:\/\/doi.org\/10.1097\/01.chi.0000242240.69678.c4","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"3097_CR24","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1001\/archpsyc.64.9.1032","volume":"64","author":"C Moreno","year":"2007","unstructured":"Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M (2007) National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Arch Gen Psychiatry 64(9):1032\u20131039. https:\/\/doi.org\/10.1001\/archpsyc.64.9.1032","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"3097_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/wps.20881","volume":"20","author":"CU Correll","year":"2021","unstructured":"Correll CU, Cortese S, Croatto G, Monaco F, Krinitski D, Arrondo G, Ostinelli EG, Zangani C, Fornaro M, Estrad\u00e9 A, Fusar-Poli P, Carvalho AF, Solmi M (2021) Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World Psychiatry 20(2):244\u2013275. https:\/\/doi.org\/10.1002\/wps.20881","journal-title":"World Psychiatry"},{"issue":"1","key":"3097_CR26","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2024.1813","volume":"68","author":"X Benarous","year":"2025","unstructured":"Benarous X, Lahaye H, Consoli A, Cohen D, Labelle R, Guil\u00e9 JM (2025) Prevalence and comorbidity rates of disruptive mood dysregulation disorder in epidemiological and clinical samples: systematic review and meta-analysis. Eur Psychiatry 68(1):e11. https:\/\/doi.org\/10.1192\/j.eurpsy.2024.1813","journal-title":"Eur Psychiatry"},{"issue":"2","key":"3097_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1017\/neu.2022.28","volume":"35","author":"MH Connors","year":"2023","unstructured":"Connors MH (2023) Paediatric bipolar disorder and its controversy. Acta Neuropsychiatr 35(2):96\u2013103. https:\/\/doi.org\/10.1017\/neu.2022.28","journal-title":"Acta Neuropsychiatr"},{"key":"3097_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jad.2020.01.020","volume":"265","author":"X Benarous","year":"2020","unstructured":"Benarous X, Renaud J, Breton JJ, Cohen D, Labelle R, Guil\u00e9 JM (2020) Are youths with disruptive mood dysregulation disorder different from youths with major depressive disorder or persistent depressive disorder? J Affect Disord 265:207\u201315. https:\/\/doi.org\/10.1016\/j.jad.2020.01.020","journal-title":"J Affect Disord"},{"issue":"1","key":"3097_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/14656566.2024.2303422","volume":"25","author":"L Orsolini","year":"2024","unstructured":"Orsolini L, Longo G, Cicolini A, Volpe U (2024) An expert opinion on the pharmacological interventions for Disruptive Mood Dysregulation Disorder (DMDD). Expert Opin Pharmacother 25(1):67\u201378. https:\/\/doi.org\/10.1080\/14656566.2024.2303422","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"3097_CR30","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jaac.2017.07.789","volume":"56","author":"F Perepletchikova","year":"2017","unstructured":"Perepletchikova F, Nathanson D, Axelrod SR, Merrill C, Walker A, Grossman M, Rebeta J, Scahill L, Kaufman J, Flye B, Mauer E (2017) Randomized clinical trial of dialectical behavior therapy for preadolescent children with disruptive mood dysregulation disorder: feasibility and outcomes. J Am Acad Child Adolesc Psychiatry 56(10):832\u201340","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"3097_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jaac.2019.05.015","volume":"59","author":"K Towbin","year":"2020","unstructured":"Towbin K, Vidal-Ribas P, Brotman MA, Pickles A, Miller KV, Kaiser A, Vitale AD, Engel C, Overman GP, Davis M, Lee B (2020) A double-blind randomized placebo-controlled trial of citalopram adjunctive to stimulant medication in youth with chronic severe irritability. J Am Acad Child Adolesc Psychiatry 59(3):350\u201361. https:\/\/doi.org\/10.1016\/j.jaac.2019.05.015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"3097_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/cap.2024.0013","volume":"34","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang W, Yu E (2024) Systematic review and meta-analysis: pharmacological and nonpharmacological interventions for disruptive mood dysregulation disorder. J Child Adolesc Psychopharmacol 34(5):217\u2013225. https:\/\/doi.org\/10.1089\/cap.2024.0013","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03097-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03097-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-026-03097-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T22:00:55Z","timestamp":1792965655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-026-03097-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3097"],"URL":"https:\/\/doi.org\/10.1007\/s00787-026-03097-1","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"26 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All data used in this retrospective observational study are de-identified in compliance with the de-identification standard defined in Section\u00a7164.514(a) of the Health Insurance Portability and Accountability Act. The University of Washington Human Subjects Division determined this study as a non-human study (IRB number: STUDY00024382); therefore, review and approval by the University of Washington Institutional Review Board were exempt.","order":1,"name":"Ethics","label":"<b>Ethics approval<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"<b>Consent to participate<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"<b>Consent to publish<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CU Correll has been a consultant and\/or advisor to or has received honoraria from: AbbVie, Alkermes, Allergan, Angelini, Aristo, Autobahn, Aytu, Axsome, Boehringer-Ingelheim, Brandaris, Bristol-Meyers Squibb, Cardio Diagnostics, Casasco, Cerevel, CNX Therapeutics, Cogstate, Compass Pathways, Darnitsa, Delpor, Denovo, Draig, Eli Lilly, Eumentis Therapeutics, Gedeon Richter, GH Research, Hetero, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen\/J&J, Karuna, LB Pharma, Lundbeck, Mapi, Maplight, MedInCell, MedLink Global, Merck, Mindpax, Mitsubishi Tanabe Pharmaceuticals, Mylan, Neumora Therapeutics, Neuraxpharm, Neurocrine, Neurelis, Neurosterix, NeuShen, Neusignal Therapeutics, Newron, Noven, Novo Nordisk, Orion Pharma, Om, Oruka, Otsuka, Phrenix, PPD Biotech, qCell, Recognify Life Science, Recordati, Relmada, Response Pharmaeutical, Reviva, Roemmers, Rovi, Saladax, Sanofi, Seqirus, Serina, Servier, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Syremis, Tabuk, Takeda, Teva, Terran, Tolmar, Vertex, Viatris and Xenon Pharmaceuticals. He provided expert testimony for Janssen, Lundbeck, Neurocrine, and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, IntraCellular Therapies, Relmada, Reviva, Rovi. He has received grant support from Boehringer-Ingelheim, Janssen and Takeda. He received royalties from UpToDate and is also a stock option or stock holder of Cardio Diagnostics, Kuleon Biosciences, LB Pharmaceuticals, MedLink Global, Mindpax, Quantic, Terran. The other authors did not have any conflict of interest to report.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}